HOOKIPA Pharma Inc.

0.91
-0.12 (-11.65%)
At close: Apr 02, 2025, 3:59 PM
0.89
-2.58%
After-hours: Apr 02, 2025, 07:51 PM EDT

HOOKIPA Pharma Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 FY 2018 FY 2017
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021 Dec 31, 2020 Dec 31, 2019 Dec 31, 2018 Dec 31, 2017
Revenue n/a 20.13M 14.25M 18.45M 19.58M 11.94M 7.63M n/a
Cost of Revenue n/a 3.55M 3.6M 4.64M 53.13M 46.31M 21.96M 398K
Gross Profit n/a 16.58M 10.65M 13.81M -33.55M -34.37M -14.34M -398K
Operating Income -51.45M -97.69M -73.16M -81.67M -53.28M -51.09M -21.18M -14.16M
Interest Income 3.7M 5.29M 8.24M 27K 9.2M 1.59M n/a n/a
Pretax Income -43.4M -81.21M -64.92M -75.67M -44.08M -43.04M -16.21M -12.72M
Net Income -43.5M -81.58M -64.92M -75.67M -44.08M -43.04M -16.24M -12.72M
Selling & General & Admin 20.23M 18.63M 18.76M 17.27M 18.08M 16.71M 6.84M 4.38M
Research & Development 68.51M 86.42M 68.64M 82.85M 54.79M 46.31M 21.96M 9.77M
Other Expenses n/a n/a -392K -2.84M 3.07M 601K 133K -25K
Operating Expenses 88.73M 117.82M 87.4M 100.12M 72.87M 63.03M 23.2M 12.09M
Interest Expense -2K 317K 687K 898K 786K 877K 778K 606K
Selling & Marketing Expenses n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses n/a 117.82M 87.4M 100.12M 72.87M 63.03M 23.2M 12.09M
Income Tax 106K 368K 230K 1K -10.28M -8.89M 24K 4K
Shares Outstanding (Basic) 12.54M 9.45M 6.55M 3.28M 2.6M 1.79M 91.44K 91.18K
Shares Outstanding (Diluted) 12.54M 9.45M 6.55M 3.28M 2.6M 1.79M 91.44K 91.18K
EPS (Basic) -3.47 -8.63 -9.91 -23.04 -16.93 -24.1 -177.58 -139.54
EPS (Diluted) -3.47 -8.63 -9.91 -23.04 -16.93 -24.1 -177.57 -139.54
EBITDA -51.45M -77.34M -60.4M -70.13M -39.15M -39.09M -14.79M -13.76M
EBIT -43.4M -80.89M -64M -74.77M -43.3M -42.16M -15.44M -12.11M
Depreciation & Amortization n/a 3.55M 3.6M 4.64M 4.15M 3.07M 640K 398K